Open positions
We are always looking for highly motivated MSc/PhD students and postdocs to join the team. If you are interested, please don’t hesitate to contact us.
DZNE Will Perform Scientific Monitoring of Use of „Leqembi“
Bonn/Germany, September 1, 2025. According to the manufacturer, the novel Alzheimer’s drug “Leqembi” will be available…
DZNE Klinikum der Universität München - Neurologische Klinik und Poliklinik Local principal investigator: Prof. Dr. Dr. Johannes Levin Local contact: Ilona Ruge +49 89 4400-46455
DZNE…
Our research questions are often exploratory – previously unknown phenomena, relationships, and structures are to be uncovered. We often deal with complex constellations of care – human and…
Exchanging knowledge and networking is an essential part of science and research. Beyond that, the DZNE invites the general public to join the dialogue on dementia research.
Events are an ideal…
Tests of the sense of smell could help identify people who are developing Alzheimer’s at an earlier stage.
Tests of the sense of smell could help identify people who are developing Alzheimer’s at an…
500,000 US Dollars in Funding for Tau Research in Munich
Mikael Simons Awarded Grant from the “Tauopathy Challenge Workshop 2025” Funding Program
Munich (Germany), August 13, 2025.…
Evidence for neuroplasticity into advanced age speaks for the lifelong adaptability of the human brain.
Evidence for neuroplasticity into advanced age speaks for the lifelong adaptability of the…
From Greifswald to Harvard
Since June, Dr. Iris Blotenberg, postdoctoral researcher in the research group of Prof. René Thyrian at the DZNE site in Rostock/Greifswald, has been conducting…
